CARLA CABALLERO: Open Payments
NPI 1063965697 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,271 in 178 payments from 17 companies in 2025. Trend: 2023 $2,321 · 2024 $3,124 · 2025 $3,271
Food & beverage: $3,187Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 41 | $708 |
| ABBVIE INC. | 35 | $543 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $399 |
| Madrigal Pharmaceuticals | 11 | $223 |
| PFIZER INC. | 11 | $193 |
| GENZYME CORPORATION | 7 | $180 |
| QOL Medical, LLC | 7 | $172 |
| Gilead Sciences, Inc. | 11 | $158 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 8 | $124 |
Products named: TREMFYA, ENTYVIO, DUPIXENT, RINVOQ, REZDIFFRA, Sucraid, VELSIPITY, MAVYRET.
Industry payments across TX — which companies pay providers there.
